Ireland
--:--IST
Latest
Clinical Trials in Norway / NCT05997329
Active, not recruiting Not applicable

Nutrition Throughout the Treatment Course - Expanding Care From Hospital to Home

NCT05997329 · tracked via the Priya Life Science Norway tracker
Phase
Not applicable
Started
2023-11-01
Last updated
2025-09-08

Condition(s) studied

Head and Neck Cancer

Investigational drug(s) / intervention(s)

App for diet record (MyFood)

App for diet record (MyFood): Patients in the intervention group will record their food intake, tube feeding, nutrition-related symptoms and body weight in the MyFood app in at least three consecutive days in advance of follow-up.The patients will thus be able to keep track of their nutrition status. They will also have access to nutrition tips for how to reach requirements if they struggle to eat sufficiently or relief symptoms that can affect food intake.Healthcare staff at the hospital and outpatient clinics will use MyFood to monitor the patient's nutrition and document this information in the electronic patient record. They will also receive decision support tailored to each individual patient, e.g. recommendations for how to use oral nutrition supplements if the patient's intake of energy or protein is too low. Patients who struggle to fulfill their requirements will receive an additional referral to a registered dietitian for nutrition treatment between week 5 and 11.

Study summary

Patients with cancer have increased risk of malnutrition due to the disease itself and the treatment regimen they undergo. This is particularly relevant for patients with head and neck cancer (HNC), where 74%-95% are malnourished. HNC is a heterogenous group of cancers, including oral cavity, larynx, pharynx and salivary glands. The present project will study the effectiveness and implementation of remote patient monitoring of nutrition and tailored nutrition support throughout the treatment course in patients with head and neck cancer. The implementation will be evaluated in a randomized controlled trial (RCT), and the aim of the project is to reduce the prevalence of malnutrition and increase the quality of life among patients with HNC.

Eligibility

Sex
ALL
Min age
18 Years
Max age
99 Years
Healthy volunteers
No
Inclusion Criteria: * Head and neck cancer * Older than 18 years Exclusion Criteria: * Patients admitted with the classification of malignant tumors (TNM) stage 4 * Terminal condition (life expectancy \< 6 months) * Patients who do not understand the Norwegian language.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
University of Oslo Oslo Oslo
Oslo University Hospital Oslo Norway

More University of Oslo trials in Norway

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05997329 on ClinicalTrials.gov ↗ ← All trials in Norway